medigraphic.com

2007, Número S1

<< Anterior Siguiente >>

Arch Cardiol Mex 2007; 77 (S1)


8. Manejo, seguimiento y pronóstico del insuficiente cardíaco compensado de etiología variada

Olvera CS, Trevethan CS, Kuri y AJ, Lacy NMC, Ilarraza LH

Idioma: Español
Referencias bibliográficas: 57
Paginas: 73-85
Archivo PDF: 106.87 Kb.


FRAGMENTO

Recomendaciones.
INC 1
• Investigar la capacidad funcional y el estado volumétrico del enfermo en cada visita con su médico.
• La evaluación de la capacidad funcional deberá realizarse mediante métodos clínicos (anamnesis, escala de NYHA, cuestionario de veteranos) puntuación de DASI.
• Se recomienda la evaluación de la capacidad funcional mediante PE en quienes la evaluación clínica de la capacidad funcional no tenga el grado de credibilidad necesaria para el médico y se requiera un método más objetivo para estratificar la magnitud de la insuficiencia cardíaca.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. The Criteria Committee of the New York Heart Association. Diseases of the heart and blood vessels: Nomenclature and criteria for diagnosis. 6th ed. Boston Mass: Little Brown, 1964.

  2. MYERS J, DO D, HERBERT W, ET AL: A normogram to predict exercise capacity from a specific activity questionnaire and clinical data. Am J Cardiol 1994; 73: 591-596.

  3. HLATKY M, BOINEAU R, HIGGENBOTHAM M, ET AL: A brief self-administered questionnaire to determine functional capacity (The Duque Activity Status Index). Am J Cardiol 1989: 64: 651-654.

  4. American Thoracic Society. Guidelines for the Six Minute Walk Test. Am Respir Crit Care Med 2002; 166: 111-117.

  5. BITTNER V, WEINER DH, YUSUF S, ET AL: For the SOLV investigators: Prediction of mortality and morbidity with a Six Minute Walk Test in patients with left ventricular dysfunction. JAMA 1993; 270: 1702-1707.

  6. STEVENS D, ELPERN E, SHARMA K, ET AL: Comparison of hallway and treadmill Six Minutes Walk Tests. Am Respir Crit Care Med 1999; 160: 1540-1543.

  7. LUCHNER A, BURNETT JC, JOUGASAKI M, ET AL: Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens 2000; 18: 1121-1128.

  8. ACC/AHA 2005 Guideline for the Diagnosis and Management of Chronic Heart Failure in the Adult. J Am Coll Cardiol 2005; 08: 022.

  9. ANDRONE AS, KATZ SD, LUND L, ET AL: Hemodilution is common in patients with advanced heart failure. Circulation 2003; 107: 226-229.

  10. FEIGENBAUM MS, WELSCH MA, MITCHELL M, VINCENT K, BRAITH RW, PEPINE CJ: Contracted plasma and blood volume in chronic heart failure. J Am Coll Cardiol 2000; 35: 51-55.

  11. MCDONALD CD, BURCH GE, WALSH JJ: Prolonged bed rest in the treatment of idiopathic cardiomyopathy. Am J Med 1972; 52: 41-50.

  12. HUNT SA, ABRAHAM WT, CHIN MH, FELDMAN AM, FRANCIS GS, GANIATS TG, JESSUP M, KONSTAM MA, MANCINI DM, MICHL K, OATES JA, RAHKO PS, SILVER MA, STEVENSON LW, YANCY CW: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). American College of Cardiology Web Site. Available at: http://www.acc.org/clinical/guidelines/failure//index.pdf.

  13. KARL SWEDBERG, CHAIRPERSON,* GOTEBORG (Sweden) Writing Committee: JOHN CLELAND, HULL (UK), HENRY DARGIE, GLASGOW (UK), HELMUT DREXLER, HANNOVER (Germany), FERENC FOLLATH, Zurich (Switzerland), MICHEL KOMAJDA, Paris (France), LUIGI TAVAZZI, Pavia (Italy), OTTO A. SMISETH, Oslo (Norway). Other Contributors: ANTONELLO GAVAZZI, BERGAMO (Italy), AXEL HAVERICH, Hannover (Germany), ARNO HOES, UTRECHT (The Netherlands), TINY JAARSMA, GRONIGEN (The Netherlands), JERZY KOREWICKI, WARSAW (Poland), SAMUEL LE´VY, Marseille (France), CECILIA LINDE, STOCKHOLM (Sweden), JOSE´-LUIS LOPEZ-SENDON, Madrid (Spain), MARKKU S. NIEMINEN, Helsinki (Finland), LUC PIE´RARD, LIE‘GE (Belgium), WILLEM J. REMME, RHOON (The Netherlands) ESC Guidelines. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26, 1115–1140.

  14. ExTraMATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) BMJ, doi:10.1136/ bmj.37938.645220.EE (published 16 January 2004).

  15. ROBERT S. MCKELVIE, MD, PHD, FRCP(C), A KOON K. TEO, MB, PHD, FRCP(C), C ROBIN ROBERTS, M.TECH, B NEIL MCCARTNEY, PHD, A DENNIS HUMEN, MD, FRCP(C), C TERENCE MONTAGUE, MD, FRCP(C), KATIE HENDRICAN, MSC, A AND SALIM YUSUF, MBBS, DPHIL, FRCP(C) A HAMILTON, Ontario, and Edmonton, Alberta, Canada. Effects of exercise training in patients with heart failure: The Exercise Rehabilitation Trial (EXERT). Am Heart J 2002;144:23-30.

  16. JONATHAN MYERS, PHD, DORIS WAGNER, MD, THOMAS SCHERTLER, MD, MEINRAD BEER, MD, ROGER LUCHINGER, MD, MAYA KLEIN, MD, HANS RICKLI, MD, PETER MULLER, MD, KURT MAYER, MD, JUERG SCHWITTER, MD, AND PAUL DUBACH: Effects of exercise training on left ventricular volumes and function in patients with nonischemic cardiomyopathy: Application of magnetic resonance myocardial tagging. Am Heart J 2002; 144: 719-725.

  17. BELARDINELLI, ROMUALDO; GEORGIOU, DEMETRIOS; CIANCI, GIOVANNI; BERMAN, NANCY; GINZTON, LEONARD; PURCARO, AUGUSTO: Cardiomyopathy/Congestive Heart Failure/Exercise Training: Exercise Training Improves Left Ventricular Diastolic Filling in Patients With Dilated Cardiomyopathy: Clinical and Prognostic Implications. Circulation 1995; 91(11): 2775-2784.

  18. HAMBRECHT, RAINER MD; FIEHN, EDUARD MD; WEIGL, CLAUDIA MD; GIELEN, STEPHAN MD; HAMANN, CAROLINE BS; KAISER, RALF BS; YU, JIANGTAO MD; ADAMS, VOLKER PHD; NIEBAUER, JOSEF MD; SCHULER, GERHARD MD: Regular Physical Exercise Corrects Endothelial Dysfunction and Improves Exercise Capacity in Patients With Chronic Heart Failure. Circulation 1998: 98(24): 2709-2715.

  19. DUBACH, PAUL MD; MYERS, JONATHAN PHD; DZIEKAN, GERALD MD; GOEBBELS, UTE MD; REINHART, WALTER MD; VOGT, PAUL MD; RATTI, RETO MD; MULLER, PETER MD; MIETTUNEN, RISTO MD; BUSER, PETER MD: Effect of Exercise Training on Myocardial Remodeling in Patients With Reduced Left Ventricular Function After Myocardial Infarction: Application of Magnetic Resonance imaging. Circulation. 1995(8): 2060-2067.

  20. HAMBRECHT, RAINER MD; GIELEN, STEPHAN MD; LINKE, AXEL MD; FIEHN, EDUARD MD; YU, JIANGTAO MD; WALTHER, CLAUDIA MD; SCHOENE, NINA MD; SCHULER, GERHARD MD: Effects of Exercise Training on Left Ventricular Function and Peripheral Resistance in Patients With Chronic Heart Failure: A Randomized Trial. JAMA 2000; 283(23): 3095-3101.

  21. MYERS J, GIANROSSI R, SCHWITTER J, WAGNER D, DUBACH P: Effect of Exercise Training on Postexercise Oxygen Uptake Kinetics in Patients With Reduced Ventricular Function. Chest 2001; 120(4).

  22. KETEYIAN, STEVEN J. PHD; LEVINE, ARLENE B. MD; BRAWNER, CLINTON A. BS; KATAOKA, TAKESHI MD; ROGERS, FELIX J. DO; SCHAIRER, JOHN R. DO; STEIN, PAUL D. MD; LEVINE, T. BARRY MD; GOLDSTEIN, SIDNEY MD: Exercise Training in Patients with Heart Failure A Randomized, Controlled Trial. Ann Intern Med 124(12): 1051-1057.

  23. BELARDINELLI R, DEMETRIOS G, GIOVANNI C, PURCARO A: Randomized, Controlled Trial of Long-Term Moderate Exercise Training in Chronic Heart Failure: Effects on Functional Capacity, Quality of Life, and Clinical Outcome. Circulation 1999(9): 1173-1182.

  24. GIANNUZZI P, TEMPORELLI P, CORRA U, GATTONE M, GIORDANO A, TAVAZZI L: Attenuation of Unfavorable Remodeling by Exercise Training in Postinfarction Patients With Left Ventricular Dysfunction: Results of the Exercise in Left Ventricular Dysfunction (ELVD) Trial. Circulation; 96(6): 1790-1797.

  25. HAMBRECHT R, FIEHN E, YU J, NIEBAUER J, WEIGL C, HILBRICH L, ADAMS V, RIEDE U, SCHULER G: Effects of Endurance Training on Mitochondrial Ultrastructure and Fiber Type Distribution in Skeletal Muscle of Patients With Stable Chronic Heart Failure. J Am Coll Cardiol. 1997; 29: 1067-1073.

  26. KIILAVUORIA K, NAVERIA H, SALMIB T, HARKONENC M: The effect of physical training on skeletal muscle in patients with chronic heart failure. Eur J Heart Fail 2000; 2: 53-63.

  27. WIELENGA RP, HUISVELD IA, BOL E, DUNSELMAN PH, ERDMAN RA, BASELIER MR, MOSTERD WL: Safety and effects of physical training in chronic heart failure. Results of the chronic Heart failure and graded exercise study (CHANGE). Eur Heart J 1999; 20(12): 872-879.

  28. COATS A, ADAMOPOULOS S, MEYER T, CONWAY J, SLEIGHT P: Effects of physical training in chronic heart failure. Lancet 1990; 335: 63-66.

  29. JETTÉ M, SÉLLER R, LANDRY F, BLÜMCHEN G: Randomized 4-week exercise program in patients with impaired left ventricular function. Circulation 1991; 84: 1561-1567.

  30. European Heart Failure Training Group. Experience from controlled trials of physical training in chronic heart failure. Eur Heart J 1998; 19: 466-475.

  31. CORRA U, ET AL: Cardiopulmonary exercise testing and prognosis in chronic heart failure. Chest 2004; 126: 942-950.

  32. ESC; Guías de práctica clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca crónica. Versión resumida (Actualización 2005). Rev Esp Cardiol 2005; 58: 1062-1092.

  33. ENNEZAT PV, ET AL: Myocardial asynchronism is a determinant of changes in functional mitral 0regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Eur Heart J 2006; 27: 679-683.

  34. KEARNEY MT ET AL: Predicting death due to progressive heart failure in patients with mild-tomoderate chronic heart failure. J Am Coll Cardiol 2002; 40: 1801-1808.

  35. KEARNEY MT, ET AL: A prognostic index to predict long-term mortality in patients with mild to moderate chronic heart failure stabilized on angiotensin converting enzyme inhibitors. Eur J Heart Fail 2003; 5: 489-497.

  36. PULIGNANO G, ET AL: Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). Am Heart J 2002; 143: 45-55.

  37. CARBONE R ET AL: Secondary pulmonary hypertension-diagnosis and management. Eur Rev Med Pharmacol Sci 2005; 9: 331-342.

  38. NEWTON JD, SQUIRE IB: Plasma glucose and haemoglobin in the assessment of prognosis following first hospitalization for heart failure. Heart 2006; 18: 1441-1446.

  39. CERESA M, ET AL: Anemia in chronic heart failure patients: comparison between invasive and non-invasive prognostic markers. Monaldi Arch Chest Dis 2005; 64(2): 124-133.

  40. HILLEGE HL, ET AL: Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113: 671-678.

  41. DE SILVA R ET AL: Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. EUR Heart J 2006; 27: 569-581.

  42. NOHRIA A, ET AL: Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2004; 41: 797-804.

  43. SPRINGER J, ET AL: Prognosis and therapy approaches of cardiac cachexia. Curr Opin Cardiol 2006; 21(3): 229-233.

  44. BALDASSERONI S, ET AL: Intraventricular conduction defects in patients with congestive heart failure: left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian Network on Congestive Heart Failure (IN-CHF database). Ital Heart J 2003; 4: 607-613.

  45. COHN JN, ET AL: Ejection fraction peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrythmias and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87: (6 suppl): VI 5-16.

  46. JANUZZI JI: Natriuretic peptide testing: a window into the diagnosis and prognosis of heart failure. Cleveland Clin Med. 2006; 73(2): 149.52, 152-157.

  47. LATINI R, ET AL: Incremental prognostic value of changes in B-type natriuretic peptide in heart failure. Am J Med 2006; 119(1): 70. 23-30.

  48. KRUGER S, ET AL: The value of cardiopulmonary exercise testing and brain natriuretic peptide plasma levels in predicting the prognosis of patients with chronic heart failure. Eur J Med 2006; 17(2): 96-101.

  49. HOGENHUIS J, ET AL: Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients. Int J Cardiol. 2006; 108(1): 63-67.

  50. DOUST JA, ET AL: How well does B-Type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. Brit Med J 2005; 330(7492): 625.

  51. SATO Y, ET AL: Biochemical markers of myocyte injury in heart failure. Heart 2004; 90: 1110-1113.

  52. KOELLING TM, ET AL: Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002; 144: 524-529.

  53. CORRA U, ET AL: Sleep and exceptional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation 2006; 113: 44-50.

  54. KEVIO G, ET AL: Use of the six-minute walk test in cardiology. Arch Mal Coeur Vaiss 2005; 98: 1219-1224.

  55. Task Force of the Italian Working Group on Rehabilitation prevention; Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part I: Definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2006; 13: 150-164.

  56. BITTENER, V ET AL: Prediction of mortality and morbility with a 6 minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA 1993; 13: 1702-1707.

  57. LA ROVERE MT, ET AL: Short-term heart rate variability predicts sudden cardiac death in chronic heart failure patients. Circulation 2003; 107: 565-570.




2020     |     www.medigraphic.com